Profile data is unavailable for this security.
About the company
Akums Drugs and Pharmaceuticals Limited is an India-based pharmaceutical contract development and manufacturing company. The Company offers a comprehensive range of pharmaceutical products and services in India and overseas. The Company’s segments include Contract Development and Manufacturing Operations (CDMO), Active Pharmaceutical Ingredient (API), Domestic Branded Formulations, International Branded Formulations, and Trade Generics. The CDMO segment is engaged in formulation research and development, preparation and regulatory filing of dossiers, manufacturing formulations on a contract basis, job work and testing services. The API segment is engaged in the manufacture and sale of key starting materials, Intermediate and API products. The Domestic Branded Formulations segment includes marketing of its branded formulations in the Indian market. The International Branded Formulations segment undertakes the marketing of its branded formulations in the global market.
- Revenue in INR (TTM)41.08bn
- Net income in INR3.17bn
- Incorporated2004
- Employees7.54k
- LocationAkums Drugs and Pharmaceuticals LtdMangolpuri Ind. AreaPhase-I, Plot No. 131 to 133, Block-CDELHI 110083IndiaIND
- Phone+91 1 169041000
- Fax+91 1 127023256
- Websitehttps://www.akums.in/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma Advanced Research Co Ltd | 531.36m | -2.68bn | 42.87bn | 316.00 | -- | -- | -- | 80.68 | -8.26 | -8.26 | 1.64 | -- | -- | -- | -- | 1,681,519.00 | -- | -60.53 | -- | -129.98 | -4.34 | -3.83 | -504.20 | -168.34 | -- | -8.82 | -- | -- | -5.00 | -1.35 | 11.55 | -- | -28.16 | -- |
| Zota Health Care Ltd | 4.73bn | -726.58m | 48.76bn | 519.00 | -- | -- | -- | 10.31 | -23.98 | -23.98 | 157.24 | -- | -- | -- | -- | 9,108,992.00 | -- | -7.79 | -- | -10.57 | 57.22 | 42.02 | -15.34 | -8.01 | -- | -3.71 | -- | -- | 62.32 | 25.23 | -293.08 | -- | 49.40 | 0.00 |
| Supriya Lifescience Ltd | 7.35bn | 1.85bn | 54.80bn | 515.00 | 29.54 | -- | 25.94 | 7.45 | 23.05 | 23.05 | 91.47 | -- | -- | -- | -- | 14,280,700.00 | -- | 18.45 | -- | 21.63 | 72.33 | 59.62 | 25.19 | 25.45 | -- | 129.43 | -- | 3.59 | 22.11 | 17.45 | 57.80 | 20.69 | 45.94 | -- |
| F D C Ltd | 20.78bn | 2.17bn | 61.27bn | 6.86k | 28.27 | -- | 22.11 | 2.95 | 13.31 | 13.31 | 127.73 | -- | -- | -- | -- | 3,030,531.00 | -- | 11.35 | -- | 12.96 | 67.92 | 60.85 | 10.43 | 14.75 | -- | 47.92 | -- | 6.34 | 8.50 | 9.42 | -12.59 | 2.15 | 25.37 | -- |
| Shilpa Medicare Ltd | 14.32bn | 1.50bn | 63.92bn | 898.00 | 42.16 | -- | 23.85 | 4.46 | 7.75 | 7.75 | 73.87 | -- | -- | -- | -- | 15,945,910.00 | -- | 2.02 | -- | 2.61 | 70.47 | 60.07 | 10.48 | 5.17 | -- | 4.67 | -- | 9.89 | 11.71 | 7.22 | 145.63 | -12.90 | 16.09 | -- |
| Aarti Pharmalabs Ltd | 18.01bn | 2.14bn | 64.29bn | 2.16k | 30.08 | -- | 20.56 | 3.57 | 23.58 | 23.58 | 200.27 | -- | -- | -- | -- | 8,324,436.00 | -- | -- | -- | -- | 53.87 | -- | 11.87 | -- | -- | 9.34 | -- | -- | 14.17 | -- | 25.59 | -- | -- | -- |
| Blue Jet Healthcare Ltd | 10.53bn | 2.94bn | 68.92bn | 491.00 | 23.46 | -- | 21.81 | 6.54 | 16.93 | 16.93 | 60.76 | -- | -- | -- | -- | 21,448,020.00 | -- | -- | -- | -- | 53.75 | -- | 27.88 | -- | -- | 59.81 | -- | -- | 44.74 | -- | 86.38 | -- | -- | -- |
| Akums Drugs and Pharmaceuticals Ltd | 41.08bn | 3.17bn | 69.10bn | 7.54k | 21.80 | 2.19 | 14.32 | 1.68 | 20.71 | 20.71 | 268.25 | 205.66 | 0.8712 | 3.69 | 4.85 | 5,450,531.00 | 6.86 | -- | 8.82 | -- | 41.18 | -- | 7.87 | -- | 3.18 | 4.98 | 0.0277 | -- | -1.44 | -- | 8,481.07 | -- | -- | -- |
| Sudeep Pharma Ltd | 6.17bn | 1.68bn | 75.49bn | -- | 43.85 | -- | 41.10 | 12.24 | 15.24 | 15.24 | 55.94 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 63.01 | -- | 27.56 | -- | -- | 55.99 | -- | -- | 9.40 | -- | 4.19 | -- | -- | -- |
| Strides Pharma Science Ltd | 47.26bn | 5.11bn | 79.05bn | 3.30k | 15.46 | -- | 10.86 | 1.67 | 55.49 | 55.49 | 512.73 | -- | -- | -- | -- | 14,315,680.00 | -- | -0.6014 | -- | -1.09 | 59.34 | 50.33 | 11.23 | -1.06 | -- | 8.50 | -- | -- | 17.36 | 10.65 | 437.22 | 52.50 | 10.08 | -22.16 |
| Marksans Pharma Ltd | 28.03bn | 3.60bn | 82.36bn | 1.35k | 22.84 | -- | 17.95 | 2.94 | 7.96 | 7.96 | 61.92 | -- | -- | -- | -- | 20,780,450.00 | -- | 14.15 | -- | 17.41 | 56.77 | 51.56 | 12.90 | 14.58 | -- | 20.42 | -- | 7.77 | 20.46 | 18.25 | 21.32 | 26.60 | 23.73 | 51.57 |
| Procter & Gamble Health Ltd | 13.49bn | 2.93bn | 82.81bn | 1.33k | 28.24 | -- | 26.18 | 6.14 | 176.64 | 176.64 | 811.45 | -- | -- | -- | -- | 10,169,760.00 | -- | -- | -- | -- | 72.49 | -- | 21.76 | -- | -- | 806.81 | -- | -- | -- | -- | -- | -- | -- | -- |
| Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 86.81bn | 3.76k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 32.29 | -- | 40.74 | -- | 92.07 | -- | 16.78 | -- | -- | -- | -- | 44.59 | 37.80 | 31.10 | 73.77 | 47.62 | -- |
| Sanofi India Ltd | 19.33bn | 3.56bn | 92.97bn | 991.00 | 26.09 | -- | 23.61 | 4.81 | 154.71 | 154.71 | 839.09 | -- | -- | -- | -- | 19,500,500.00 | -- | 22.31 | -- | 31.44 | 51.42 | 54.10 | 18.44 | 21.53 | -- | 321.27 | -- | 132.73 | 0.8567 | -8.10 | -13.96 | -5.41 | -13.65 | 1.99 |
| Viyash Scientific Ltd | 21.26bn | 768.08m | 94.36bn | 1.24k | 91.13 | -- | 46.88 | 4.44 | 2.37 | 2.37 | 70.40 | -- | -- | -- | -- | 17,086,170.00 | -- | 0.4014 | -- | 0.6553 | 51.15 | 42.16 | 4.52 | 0.4199 | -- | 3.92 | -- | 995.91 | 13.26 | 5.64 | 160.99 | -20.73 | -0.126 | -- |
| Corona Remedies Ltd | 13.44bn | 1.71bn | 97.43bn | 4.57k | 56.87 | -- | 46.63 | 7.25 | 28.01 | 28.01 | 219.70 | -- | -- | -- | -- | 2,980,876.00 | -- | -- | -- | -- | 81.28 | -- | 12.75 | -- | -- | 55.10 | -- | -- | 17.93 | -- | 65.11 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to Akums Drugs and Pharmaceuticals Ltd's reporting currency: Indian Rupee INR
12.30%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| ICICI Prudential Asset Management Co. Ltd. (Invt Mgmt)as of 31 Jan 2026 | 7.73m | 4.91% |
| Franklin Templeton Asset Management (India) Pvt Ltd.as of 30 Jan 2026 | 6.57m | 4.18% |
| Bandhan AMC Ltd.as of 31 Jan 2026 | 1.75m | 1.11% |
| Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Dec 2025 | 1.57m | 1.00% |
| Border to Coast Pensions Partnership Ltd.as of 30 Sep 2025 | 1.55m | 0.99% |
| Causeway Capital Management LLCas of 28 Nov 2025 | 107.46k | 0.07% |
| HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Jan 2026 | 32.92k | 0.02% |
| SBI Funds Management Ltd.as of 31 Jan 2026 | 21.40k | 0.01% |
| Motilal Oswal Asset Management Co. Ltd.as of 31 Dec 2025 | 20.89k | 0.01% |
| ICICI Prudential Life Insurance Co. Ltd. (Invt Port)as of 31 Jan 2026 | 8.78k | 0.01% |
More ▼
Data from 31 Dec 2025 - 10 Feb 2026Source: FactSet Research Systems Inc.
